The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ubs Oncology Impact Fund L.p. since year 2005.
The trader's CIK number is 1691428.
At the time of this reporting, Ubs Oncology Impact Fund L.p. is the of Sunesis Pharmaceuticals Inc .
(stock ticker symbol SNSS).
See this page for all insider trading activities at Sunesis Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-06||SNSS||Sunesis Pharmaceuticals Inc||Buy||16,200||2.77||44,874|
|2017-11-03||SNSS||Sunesis Pharmaceuticals Inc||Buy||40,000||2.89||115,600|
|2017-11-02||SNSS||Sunesis Pharmaceuticals Inc||Buy||25,300||2.59||65,527|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ubs Oncology Impact Fund L.p. ( of Sunesis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.